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Identity 
Other names: CNSA2; EEN-B1; Endophilin-1; 
FLJ20276; FLJ25015; OTTHUMP00000021084; 
SH3D2A; SH3P4 
HGNC (Hugo): SH3GL2 
Location: 9p22.2 
Local order: Next to ADAMTSL1 and FAN154A. 
DNA/RNA 
Description 
10 exons; spans 217.93kb. 
Transcription 
mRNA of 2483 and 2417bp (there are two transcripts). 
Protein 
Description 
352 amino acids; 39.96kDa and 330 amino acids; 
37.51kDa. 
Expression 
Highest expression found in brain followed by pituitary 
gland and kidney. Expression has also been reported in 
bladder, eye, heart, cervix, breast, head and neck 
tissues etc. 
Localisation 
Cytoplasmic (diffuse cytoplasmic distribution in resting 
cells and a colocalization with EGF receptor in 
endocytic vesicles after EGF stimulation). 
Function 
SH3GL2 is a presynaptic protein that binds to dynamin, 
a GTPase that is implicated in endo-cytosis and  
recycling of synaptic vesicles. SH3GL2 by its LPAAT 
activity may induce negative membrane curvature by 
converting an inverted cone shaped lipid to a cone 
shaped lipid in the cytoplasmic leaflet of the bilayer. 
Through this action, SH3GL2 works with dynamin to 
mediate synaptic vesicle invagination from the plasma 
membrane and fission. SH3GL2 in complex with CBL 
and CIN85 participates in activated EGF receptor 
(Stimulated by EGF) endocytosis from the membrane 
surface and its subsequent lysosomal degradation. 
The SH3 domain of SH3GL2 binds to a 24 amino acid 
proline rich domain (PRD) in the third intracellular 
loop of the G-protein coupled-1-adrenergic receptor. 
SH3GL2 overexpression increased isoproterenol-
induced receptor inter-nalization by 25% and decreased 
coupling of receptor to the G-protein. 
The SH3 domain of SH3GL2 also binds to a proline 
rich domain within the cytoplasmic tail of metallo-
protease disintegrins, transmembrane glycoproteins 
acting in cell adhesion and growth factor signaling. 
SH3GL2 binds preferentially to the pro-form found in 
the trans-Golgi network. Therefore SH3GL2 binding 
may regulate intracellular transit and maturation of 
metalloprotease disintegrin. 
Rat germinal centre kinse-like kinase (rGLK), a 
serine/threonine cytosolic kinase, interacted with 
SH3GL2. rGLK modulated c-Jun N-terminal kinase 
(JNK) activity by phosphorylation and binds to the  
SH3 domain of SH3GL2 through a C-terminal proline 
rich domain. Coexpression of rGLK and full length 
SH3GL2 increased JNK activity two fold, whereas 
coexpression with the SH3 domain of SH3GL2 
abrogated rGLK-induced JNK activation. SH3GL2, 
therefore, modulated the mitogen-activated protein 
kinase pathway through physical association with 
rGLK. 
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Homology 
SH3GL2 contains a C-terminal SH3 domain, which 
shares 92% and 84% amino acid sequence homology 
with the SH3 domain of SH3GL3 and SH3GL1, 
respectively. The SH3 domain of SH3GL2 also shows 









Reduced expressions of SH3GL2 due to different types 
of molecular alterations are involved in tumor 
formation in head and neck, breast and gastric tissues. 
Prognosis 
The prognostic significance of down regulation of 
SH3GL2 in sporadic tumors is not understood clearly. 
Cytogenetics 
Chromosomal deletions, chromosomal gain or 
amplification and chromosomal breakpoints are 
frequent. 
Oncogenesis 
LOH on 9p22 is one of the most frequent events 
identified in head and neck tumor, breast carcinoma, 
pituitary adenoma, neuroblastoma etc. However, 
promoter methylation appears to be another common 
mechanism of SH3GL2 inactivation. 
Alzheimer disease 
Disease 
The increased expression level of SH3GL2 in neuron is 
linked to an increase in the activation of the stress 
kinase c-Jun N-terminal kinase with the subsequent 
death of the neuron. 
Prognosis 
SH3GL2 overexpression is now considered as a new 




Increase in aneuploidy or aberration, but chromosomal 
loss or gain in aneuploid cell was not specific. In some 
forms of Alzheimer disease, a specific type of 
aneuploidy-trisomy 21 mosaicism has been reported. 
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